The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with FCT, Universidade NOVA de Lisboa

14 Sep 2016 11:50

RNS Number : 8333J
Frontier IP Group plc
14 September 2016
 

AIM: FIPP

14 September 2016

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

Agreement with the Faculty of Science and Technology of Universidade NOVA de Lisboa

 

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that it has today signed an agreement with the Faculty of Science and Technology within the Universidade NOVA de Lisboa, Portugal ("FCT NOVA") to assist with its spin-off and licensing activities emerging from its research programmes. This partnership is Frontier IP's second in Portugal and reflects the Group's view that there is significant opportunity in the region.

 

The Universidade NOVA de Lisboa is a research-intensive university (QS Top Universities 2016) and FCT NOVA, its engineering school, has particular research strengths in Materials, Environment, Energy, Biotechnology, Conservation and Restoration. Frontier IP and FCT NOVA will work together to maximise the commercial value of intellectual property developed within or owned by FCT NOVA. Frontier IP will receive a share of equity in each spin-off company created by FCT NOVA, as well as a share in the licensing revenue it receives.

 

FCT NOVA is an active research collaborator, both within Portugal and internationally, and its partners include Massachusetts Institute of Technology (MIT), the University of Carnegie Mellon and the University of Texas at Austin, amongst others. The collaboration with Frontier IP aims to accelerate value creation from the research generated within FCT NOVA and provide access to early stage funding, commercialisation expertise and a wider network of industrial partners.

 

The signing of the agreement was attended by Her Majesty's Ambassador to the Portuguese Republic, Mrs Kirsty Hayes. Addressing the audience, the Ambassador emphasised the importance of effective commercialisation of the intellectual property being generated through the investment in research and development in Portugal's universities. The UK has strong experience of intellectual property commercialisation and it has been a principle focus for British universities to develop a portfolio of intellectual property which has relevance to the business world.

 

Her Majesty's Ambassador to the Portuguese Republic, Mrs Kirsty Hayes, said:

 

"I am delighted by the announcement of this important agreement between Frontier IP and FCT NOVA, which will drive the commercialisation of intellectual property from one of the leading Portuguese universities, which has a strong reputation for investment in research and development. This agreement represents a further strengthening of collaboration between Portugal and the United Kingdom."

 

Neil Crabb, Chief Executive of Frontier IP, said:

 

"We are delighted that FCT NOVA has chosen us as its commercialisation partner. This agreement gives us access to FCT NOVA's excellent research base and builds on the strong relationships with the industrial partners and academic institutions which we have already established in the region. We are looking forward to working with FCT NOVA to further develop and commercialise its strong intellectual property portfolio."

 

Dr. Fernando Santana, Director of FCT NOVA, said:

 

"Frontier IP has a strong reputation in the commercialisation of university-based technologies. We hope that this agreement will bring increased international visibility to FCT NOVA's portfolio, making it an even more successful institution by maximizing the impact of its knowledge. This shows FCT NOVA's commitment to innovation, which benefits the institution and the wider society it serves."

 

Enquiries

 

Frontier IP Group Plc

 

T: 0131 240 1251

Neil Crabb, Chief Executive

 

 

Company website: www.frontierip.co.uk

 

 

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

 

T: 020 7894 7000

David Foreman, Catherine Leftley, Corporate Finance

 

 

David Banks, Sales

 

 

 

 

 

Peterhouse Corporate Finance Limited

(Joint Broker)

 

T: 020 7469 0935

Lucy Williams

 

 

 

 

 

Kreab

 

T: 020 7074 1800

Robert Speed, Matthew Jervois

 

 

 

 

Notes to Editor:

 

About Frontier IP Group plc

www.frontierip.co.uk 

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses.

 

About Universidade NOVA de Lisboa, Faculty of Science and Technology

http://www.fct.unl.pt

FCT NOVA is one of the most prestigious Portuguese engineering and science public schools and it is engaged in extensive research activity developed in 16 research centres involving 1600 PhD and Master's students and a total of 550 academic staff (90% holding a Ph.D). FCT NOVA partners with foreign universities such as the Massachusetts Institute of Technology (MIT), the University of Carnegie Mellon and the University of Texas at Austin to offer some of its advanced study programs. The entrepreneurial drive of the students and graduates of FCT NOVA has led to many successful spin-offs that transfer knowledge to the market and help create value and social impact.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLLFSIARISLIR
Date   Source Headline
9th Dec 20197:00 amRNSGrant of Options
6th Dec 20196:25 pmRNSHolding(s) in Company
5th Dec 201912:00 pmRNSHolding(s) in Company
4th Dec 201912:00 pmRNSResult of AGM & Total Voting Rights
26th Nov 201912:58 pmRNSHolding(s) in Company
13th Nov 20195:00 pmRNSPosting of Annual Report and Accounts
7th Nov 201912:20 pmRNSHolding(s) in Company
6th Nov 20192:00 pmRNSResult of Placing
6th Nov 20197:01 amRNSProposed fundraising of £3.5m by way of Placing
6th Nov 20197:00 amRNSFinal Results
22nd Oct 20197:00 amRNSAppointment of senior advisers
15th Oct 20197:00 amRNSNew portfolio company: Elute Intelligence Holdings
10th Sep 20197:00 amRNSAppointment of Broker
25th Jul 20197:00 amRNSExscientia collaboration with Rallybio
15th Jul 201912:08 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSExscientia partnership with GT Apeiron
31st May 20195:00 pmRNSTotal Voting Rights
31st May 20193:15 pmRNSDirectorate Change
28th May 20197:00 amRNSFieldwork Robotics completes initial field trials
15th May 20197:00 amRNSDirector exercise of options, shareholding and TVR
10th May 201911:48 amRNSHolding(s) in Company
30th Apr 20197:00 amRNSEuropean plan to boost marine & coastal economies
8th Apr 20197:00 amRNSParkside Architectural Tiles launch Alusid range
8th Apr 20197:00 amRNSBosch UK to work with Pulsiv Solar
8th Apr 20197:00 amRNSInvestor event at the Royal Academy of Engineering
4th Apr 20197:00 amRNSExscientia reaches first major milestone with GSK
3rd Apr 20195:51 pmRNSHolding(s) in Company
3rd Apr 20193:45 pmRNSHolding(s) in Company
1st Apr 20197:00 amRNSFieldwork Robotics wins Innovate UK ISCF grant
27th Mar 20191:30 pmRNSHolding(s) in Company
27th Mar 20191:30 pmRNSHolding(s) in Company
27th Mar 20197:00 amRNSBoard Appointment
27th Mar 20197:00 amRNSUnaudited Half Year Results
21st Mar 20199:18 amRNSTrading Update
21st Mar 20199:14 amRNSExscientia & Celgene drug discovery collaboration
6th Mar 20195:15 pmRNSHolding(s) in Company
20th Feb 20197:00 amRNSTVG - key partner in $9.67m DARPA project award
12th Feb 20197:00 amRNSThird Portuguese spin out: Insignals Neurotech
4th Feb 20197:00 amRNSAmprologix wins DHSC backing for new antibiotic
31st Jan 20199:00 amRNSNandi Proteins led consortium wins UK grant
25th Jan 20197:00 amRNSThe Vaccine Group wins Department of Health grant
7th Jan 20191:29 pmRNSExscientia Series B funding & Roche collaboration
27th Dec 20187:00 amRNSMolendotech - Palintest start commercial roll out
19th Dec 201811:45 amRNSResult of AGM
30th Nov 20185:30 pmRNSTotal Voting Rights
23rd Nov 201812:10 pmRNSPosting of Annual Report and Notice of AGM
22nd Nov 20181:12 pmRNSHolding(s) in Company
22nd Nov 201810:36 amRNSHolding(s) in Company
21st Nov 20183:30 pmRNSHolding(s) in Company
21st Nov 201811:00 amRNSTotal Voting Rights and Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.